Evert B. Schimmelpennink

President, CEO and Secretary

Evert B. Schimmelpennink (President, CEO and Secretary) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in LENZ. Across 1 priced purchase filing, the average 21-session return was +9.7% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $251K of LENZ (28,089 sh × $8.95, as filed), executed Mar 27.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+9.7%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+3.2%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$251K

shares × price, as filed

Last traded

Mar 27

Filed Mar 30

Open performance→

Volume by month

Buys $251K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

LENZ LENZ LENZ · 1 buy · 0 sells 1 filing

Recent filings

LENZPURCHASE LENZ Therapeutics, Inc. View filing → $251K
28,089 sh × $8.95
Exec Mar 27
Filed Mar 30 · 8:46 AM ET